Baillieu Holst noted: "We initiate coverage of Danakali with a BUY recommendation and target price of $0.50ps on a diluted basis based on our modelling of the NPV over time."
↧
Baillieu Holst noted: "We initiate coverage of Danakali with a BUY recommendation and target price of $0.50ps on a diluted basis based on our modelling of the NPV over time."